← Open Payments lookup

DAVE FIELDS: Open Payments

NPI 1598423964 · MILILANI, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,433 in 57 payments from 13 companies in 2025. Trend: 2023 $2,209 · 2024 $1,171 · 2025 $1,433

Food & beverage: $1,433
CompanyPaymentsAmount
Alkermes, Inc.14$378
Otsuka Pharmaceutical Development & Commercialization, Inc.4$341
ABBVIE INC.9$194
Teva Pharmaceuticals USA, Inc.10$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$140
Janssen Pharmaceuticals, Inc3$81
E.R. Squibb & Sons, L.L.C.1$33
Indivior Inc.1$25
Otsuka America Pharmaceutical, Inc.1$25
Vanda Pharmaceuticals Inc.1$22

Products named: ARISTADA, VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR, CAPLYTA, VIVITROL, INVEGA SUSTENNA, REXULTI.

Industry payments across HI — which companies pay providers there.